Skip to main content

Table 2 KOOS changes between the follow-up visits (T3 and T1) and baseline FAS population

From: Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study

 BCL high dose, mean ± SDBCL low dose, mean ± SDPlacebo, mean ± SD
KOOS change at T1 (difference between T1 and baseline)N494645
Global score35.2 ± 67.518.0 ± 57.67.9 ± 60.2
Pain7.1 ± 17.54.8 ± 16.73.1 ± 13.9
Symptoms6.7 ± 15.22.9 ± 13.61.7 ± 14.6
Function in daily living (ADL)5.9 ± 19.64.0 ± 16.51.4 ± 13.2
Function in sport and recreation (sport/rec)10.5 ± 18.04.2 ± 16.72.3 ± 15.4
Knee-related quality of life (QoL)5.6 ± 14.83.1 ± 14.9− 0.2 ± 16.2
KOOS change at T3 (difference between T3 and baseline)N473840
Global score56.3 ± 82.648. ± 73.142.1 ± 66.2
Pain12.3 ± 19.412.8 ± 18.410.8 ± 16.5
Symptoms10.0 ± 16.67.4 ± 16.07.5 ± 14.7
Function in daily living (ADL)9.2 ± 19.510.3 ± 20.97.3 ± 14.6
Function in sport and recreation (sport/rec)11.1 ± 20.59.6 ± 15.39.7 ± 17. 8
Knee related quality of life (QoL)12.4 ± 20.39.2 ± 19.36.6 ± 16.8